COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, Alessio Bruni, Michela Buglione di Monale e Bastia, Gianpiero Catalano, Andrea Riccardo Filippi, Pierfrancesco Franco, Maria Antonietta Gambacorta, Domenico Genovesi, Giuseppe Iatì, Alessandro Magli, Luigi Marafioti, Icro Meattini, Anna Merlotti, Marcello Mignogna, Daniela Musio, Roberto Pacelli, Stefano Pergolizzi, Vincenzo TomboliniMarco Trovò, Umberto Ricardi, Stefano Maria Magrini, Renzo Corvò, Vittorio Donato

Research output: Contribution to journalArticlepeer-review

Abstract

Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.

Original languageEnglish
Pages (from-to)89-93
Number of pages5
JournalRadiotherapy and Oncology
Volume149
DOIs
Publication statusPublished - Aug 2020

Keywords

  • AIRO (Italian Association of Radiotherapy and Clinical Oncology)
  • COVID-19
  • Italy
  • Radiation oncology
  • Survey

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)'. Together they form a unique fingerprint.

Cite this